Kite Pharma to Present at November 2016 Investor Conferences

SANTA MONICA, Calif.--(BUSINESS WIRE)-- Kite Pharma, Inc. (Nasdaq:KITE) today announced that management will present at three investor conferences in November:

Credit Suisse 25^th Annual Healthcare Conference

• Date: Monday, November 7, 2016
• Time: 2:30pm Mountain Time
• Location: Phoenix, AZ

Jefferies London Healthcare Conference

• Date: Wednesday, November 16, 2016
• Time: 10:00am Greenwich Mean Time
• Location: London, UK

Stifel 2016 Healthcare Conference

• Date: Wednesday, November 16, 2016
• Time: 1:30 PM Eastern Time
• Location: New York, NY

A live audio webcast of each event will be available on the Investors section of Kite's website, www.kitepharma.com. A replay of each webcast will be available on the website for approximately 30 days.

About Kite Pharma

Kite Pharma, Inc. is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a primary focus on engineered autologous cell therapy (eACT™) designed to restore the immune system's ability to recognize and eradicate tumors. Kite is based in Santa Monica, CA. For more information on Kite Pharma, please visit www.kitepharma.com. Sign up to follow @KitePharma on Twitter at www.twitter.com/kitepharma.

View source version on businesswire.com: http://www.businesswire.com/news/home/20161028005154/en/

Kite Pharma, Inc.Christine CassianoSVP, Corporate Communications & Investor Relationsccassiano@kitepharma.comorGreg MannVP, Investor Relationsgmann@kitepharma.com

Source: Kite Pharma, Inc.

News Provided by Acquire Media